REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/06/2025
Back to search
Official data from USPTO
FERMISH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/07/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
03/22/2016
Registration date
12/06/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2023
Last transaction
12/07/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
New Delhi, IN
Examiner
ZAK, HENRY
Law office
N10
Current location
TMO LAW OFFICE 119
Mark description
The mark consists of a rectangle followed by the word "FERMISH"; the first arm of the letter "M" consists of a representation of a chemical single bond.
Holders and representatives
Holders
FERMISH CLINICAL TECHNOLOGIES (P) LTD.
Representatives
Jaeyoung Chon Sinorica LLC dba Thoughts to Paper
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Basic and clinical research in the field of respiratory science and medicine; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncologycardiovascularneurology; Cosmetics research; Cosmetics research for others; Medical research; Pharmaceutical product evaluation; Pharmaceutical research services; Research and development of technology in the field of pharmaceuticals; Scientific investigations for medical purposes; Scientific research; Scientific research in the field of pharmaceuticals; Scientific research in the field of Medicines; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Toxicology services
Publications
History of USPTO decisions and trademark events.
23 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2016
PUBO
PUBLISHED FOR OPPOSITION
09/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/18/2016
ALIE
ASSIGNED TO LIE
08/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2016
GNRT
NON-FINAL ACTION E-MAILED
07/08/2016
CNRT
NON-FINAL ACTION WRITTEN
07/08/2016
DOCK
ASSIGNED TO EXAMINER
07/05/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2016
NWAP
NEW APPLICATION ENTERED
04/08/2016
Continuous trademark protection
Get notified about every new filing that threatens FERMISH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.